FinnCap reaffirmed their corporate rating on shares of Omega Diagnostics Group Plc (LON:ODX) in a report issued on Monday. They currently have a GBX 28 ($0.34) target price on the stock.

Omega Diagnostics Group Plc (LON:ODX) opened at 18.70 on Monday. The stock’s market cap is GBX 20.34 million. The stock has a 50 day moving average price of GBX 16.93 and a 200 day moving average price of GBX 16.79. Omega Diagnostics Group Plc has a 52-week low of GBX 13.50 and a 52-week high of GBX 21.00.

Omega Diagnostics Group Plc Company Profile

Omega Diagnostics Group PLC, based in the United Kingdom, is a holding company. The Company, along with its subsidiaries is engaged in manufacture, development and distribution of medical diagnostics products. The Company operates in three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease and Other.

Receive News & Stock Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related stocks with our FREE daily email newsletter.